177 related articles for article (PubMed ID: 29153715)
1. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
3. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
[TBL] [Abstract][Full Text] [Related]
4. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
[TBL] [Abstract][Full Text] [Related]
5. A Facile Multi-interface Transformation Approach to Monodisperse Multiple-Shelled Periodic Mesoporous Organosilica Hollow Spheres.
Teng Z; Su X; Zheng Y; Zhang J; Liu Y; Wang S; Wu J; Chen G; Wang J; Zhao D; Lu G
J Am Chem Soc; 2015 Jun; 137(24):7935-44. PubMed ID: 26030506
[TBL] [Abstract][Full Text] [Related]
6. Biphasic-to-monophasic successive Co-assembly approach to yolk-shell structured mesoporous organosilica nanoparticles.
Dang M; Teng Z; Su X; Tao J; Hao Q; Ma X; Zhang Y; Li Y; Tian Y; Zhang J; Lu G; Wang L
J Colloid Interface Sci; 2017 Dec; 507():242-249. PubMed ID: 28800448
[TBL] [Abstract][Full Text] [Related]
7. Size effect of mesoporous organosilica nanoparticles on tumor penetration and accumulation.
Zhang J; Wang X; Wen J; Su X; Weng L; Wang C; Tian Y; Zhang Y; Tao J; Xu P; Lu G; Teng Z; Wang L
Biomater Sci; 2019 Nov; 7(11):4790-4799. PubMed ID: 31524909
[TBL] [Abstract][Full Text] [Related]
8. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
9. Small size mesoporous organosilica nanorods with different aspect ratios: Synthesis and cellular uptake.
Li Y; Guo W; Su X; Ou-Yang L; Dang M; Tao J; Lu G; Teng Z
J Colloid Interface Sci; 2018 Feb; 512():134-140. PubMed ID: 29055795
[TBL] [Abstract][Full Text] [Related]
10. Virus-mimicking mesoporous organosilica nanocapsules with soft framework and rough surface for enhanced cellular uptake and tumor penetration.
Tao J; Chen K; Su X; Ren L; Zhang J; Bao L; Dong H; Lu G; Teng Z; Wang L
Biomater Sci; 2020 Apr; 8(8):2227-2233. PubMed ID: 32129325
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
12. Facile synthesis of yolk-shell structured monodisperse mesoporous organosilica nanoparticles by a mild alkalescent etching approach.
Tao J; Dang M; Su X; Hao Q; Zhang J; Ma X; Lu G; Zhang Y; Tian Y; Weng L; Teng Z; Wang L
J Colloid Interface Sci; 2018 Oct; 527():33-39. PubMed ID: 29775819
[TBL] [Abstract][Full Text] [Related]
13. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis of Yolk-Shell-Structured Triple-Hybridized Periodic Mesoporous Organosilica Nanoparticles for Biomedicine.
Teng Z; Zhang J; Li W; Zheng Y; Su X; Tang Y; Dang M; Tian Y; Yuwen L; Weng L; Lu G; Wang L
Small; 2016 Jul; 12(26):3550-8. PubMed ID: 27183872
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy.
Shao D; Zhang F; Chen F; Zheng X; Hu H; Yang C; Tu Z; Wang Z; Chang Z; Lu J; Li T; Zhang Y; Chen L; Leong KW; Dong WF
Adv Mater; 2020 Dec; 32(50):e2004385. PubMed ID: 33164250
[TBL] [Abstract][Full Text] [Related]
16. Deformable Hollow Periodic Mesoporous Organosilica Nanocapsules for Significantly Improved Cellular Uptake.
Teng Z; Wang C; Tang Y; Li W; Bao L; Zhang X; Su X; Zhang F; Zhang J; Wang S; Zhao D; Lu G
J Am Chem Soc; 2018 Jan; 140(4):1385-1393. PubMed ID: 29281272
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
[TBL] [Abstract][Full Text] [Related]
19. Facile synthesis of mesoporous organosilica nanobowls with bridged silsesquioxane framework by one-pot growth and dissolution mechanism.
Du X; Li W; Shi B; Su L; Li X; Huang H; Wen Y; Zhang X
J Colloid Interface Sci; 2018 Oct; 528():379-388. PubMed ID: 29870824
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable Mesoporous Organosilica Nanosheets for Chemotherapy/Mild Thermotherapy of Cancer: Fast Internalization, High Cellular Uptake, and High Drug Loading.
Chen L; Meng X; Liu M; Lv R; Cai B; Wang Z
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30234-30246. PubMed ID: 32525649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
